S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
Free Trial

Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$14.74
$14.62
$6.38
▼
$14.76
$1.87B0.193.08 million shs3.45 million shs
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00%0.00%0.00%0.00%+2.08%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$15K124,613.93N/AN/A$3.09 per share4.77

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BELLUS Health Inc. stock logo
BLU
BELLUS Health
-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/A
33.42
33.42

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
90.37%

Insider Ownership

CompanyInsider Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
24.17%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BELLUS Health Inc. stock logo
BLU
BELLUS Health
74126.81 million96.16 millionNot Optionable

BLU, BVXP, and NCYT Headlines

SourceHeadline
Dignity Health reaches in-network coverage deal with Blue Cross Blue Shield of ArizonaDignity Health reaches in-network coverage deal with Blue Cross Blue Shield of Arizona
ktar.com - March 21 at 7:11 PM
Deal reached between Dignity Health, Arizona Blue Cross Blue ShieldDeal reached between Dignity Health, Arizona Blue Cross Blue Shield
msn.com - March 21 at 7:08 AM
The effects of blue light on human health are still unclear, says panelThe effects of 'blue light' on human health are still unclear, says panel
msn.com - March 4 at 11:37 PM
School of Public HealthSchool of Public Health
unr.edu - March 3 at 12:24 PM
Health Beat: Blue light exposureHealth Beat: Blue light exposure
wfmz.com - February 9 at 9:27 AM
Blue Bridge glows red for heart healthBlue Bridge glows red for heart health
woodtv.com - February 3 at 1:06 AM
Health care jeopardized for millions of Californians: Anthem Blue Cross vs. UCSF HealthHealth care jeopardized for millions of Californians: Anthem Blue Cross vs. UCSF Health
ktvu.com - January 26 at 10:30 PM
Glowing blue waves off Orange County coast make for thrilling start to New YearGlowing blue waves off Orange County coast make for thrilling start to New Year
msn.com - January 4 at 8:57 PM
Analysts Are Bullish on These Healthcare Stocks: Bluebird Bio (BLUE), United Therapeutics (UTHR)Analysts Are Bullish on These Healthcare Stocks: Bluebird Bio (BLUE), United Therapeutics (UTHR)
markets.businessinsider.com - December 21 at 7:05 PM
FDA holds back MSD’s chronic cough drug againFDA holds back MSD’s chronic cough drug again
pharmaphorum.com - December 21 at 7:47 AM
5 Best Blu-Ray and DVD Players You Can Still Buy in 20235 Best Blu-Ray and DVD Players You Can Still Buy in 2023
esquire.com - November 2 at 9:47 AM
Brazil: Federal govt instructs States to issue animal health alert over bird bluBrazil: Federal gov't instructs States to issue animal health alert over bird blu
en.mercopress.com - September 27 at 6:38 PM
CBD Dosage: How Much Should You Take?CBD Dosage: How Much Should You Take?
forbes.com - September 21 at 9:52 AM
BELLUS Health Inc. [BLU] Shares Jump Approximately 62.16% Over the YearBELLUS Health Inc. [BLU] Shares Jump Approximately 62.16% Over the Year
knoxdaily.com - June 29 at 1:09 PM
GSK completes acquisition of BELLUS HealthGSK completes acquisition of BELLUS Health
pharmiweb.com - June 29 at 8:09 AM
Bellus Health (NASDAQ: BLU)Bellus Health (NASDAQ: BLU)
fool.com - June 28 at 3:39 AM
These Canadian Biotech Stocks Are Quietly Changing the Face of HealthcareThese Canadian Biotech Stocks Are Quietly Changing the Face of Healthcare
msn.com - June 27 at 8:42 PM
BLU.TO - BELLUS Health Inc.BLU.TO - BELLUS Health Inc.
finance.yahoo.com - June 25 at 10:54 PM
BTIG Reaffirms Their Hold Rating on BELLUS Health (BLU)BTIG Reaffirms Their Hold Rating on BELLUS Health (BLU)
markets.businessinsider.com - June 17 at 2:52 PM
TSX Stocks in the Healthcare Industry: Which Ones Are Worth Your Money?TSX Stocks in the Healthcare Industry: Which Ones Are Worth Your Money?
ca.finance.yahoo.com - May 10 at 6:46 PM
Should You Buy Bellus Health (BLU) After Golden Cross?Should You Buy Bellus Health (BLU) After Golden Cross?
finance.yahoo.com - May 10 at 1:10 PM
Closing Bell: Bellus Health Inc up on Tuesday (BLU)Closing Bell: Bellus Health Inc up on Tuesday (BLU)
theglobeandmail.com - May 2 at 7:16 PM
BELLUS Health: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BLU)BELLUS Health: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BLU)
theglobeandmail.com - April 26 at 7:08 PM
BELLUS Health Announces Meeting UpdatesBELLUS Health Announces Meeting Updates
finance.yahoo.com - April 26 at 7:08 PM

New MarketBeat Followers Over Time

Top Headlines

All Headlines

Company Descriptions

BELLUS Health logo

BELLUS Health

NASDAQ:BLU
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.